Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaume Capdevila

Showing results (41-50 of 192) with videos related to

Pageof 20
Sort By:
Cancer Chemotherapy and Pharmacology|December 7, 2014
Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumorsDaniel Castellano, Enrique Grande, Juan Valle, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|January 4, 2025
Genomics Review of Selective RET Inhibitors Sensitivity in Thyroid Cancer Clinical TrialsSara Gil-Bernabé, Lucía García-DeLaFuente, Alejandro García-Álvarez, et al.
Endocrine Reviews|October 27, 2022
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor HypoxiaRodrigo A Toledo, Camilo Jimenez, Gustavo Armaiz-Pena, et al.
Cancer Treatment Reviews|July 8, 2014
RAF signaling in neuroendocrine neoplasms: from bench to bedsideNicola Fazio, Omar Abdel-Rahman, Francesca Spada, et al.
Endocrine-Related Cancer|August 1, 2025
Lenvatinib as salvage therapy in advanced and progressive GI-NETAnnie Mathew, Jaume Capdevila, Nicole Unger, et al.
Current Opinion in Oncology|May 5, 2009
Development of new drug strategies in infrequent digestive tumors: esophageal, biliary tract, and anal cancersJaume Capdevila, Francisco Javier Ramos, Teresa Macarulla, et al.
Cancer Treatment Reviews|December 25, 2024
Maintenance therapy after first-line platinum-based chemotherapy in gastroenteropancreatic neuroendocrine carcinomas: A literature reviewNatalia Soledad Tissera, Francesca Balconi, Alejandro García-Álvarez, et al.
Therapeutic Advances in Medical Oncology|August 4, 2022
Cabozantinib combination therapy for the treatment of solid tumors: a systematic reviewDaniel Castellano, Andrea B Apolo, Camillo Porta, et al.
Cancer Treatment Reviews|July 23, 2018
Optimisation of treatment with lenvatinib in radioactive iodine-refractory differentiated thyroid cancerJaume Capdevila, Kate Newbold, Lisa Licitra, et al.
Current Oncology Reports|August 22, 2023
Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line TreatmentNikolaos Andreatos, Patrick W McGarrah, Mohamad Bassam Sonbol, et al.
Pageof 20

Showing results (41-50 of 192) with videos related to

Sort By:
Pageof 20
Cancer Chemotherapy and Pharmacology|December 7, 2014
Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumorsDaniel Castellano, Enrique Grande, Juan Valle, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|January 4, 2025
Genomics Review of Selective RET Inhibitors Sensitivity in Thyroid Cancer Clinical TrialsSara Gil-Bernabé, Lucía García-DeLaFuente, Alejandro García-Álvarez, et al.
Endocrine Reviews|October 27, 2022
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor HypoxiaRodrigo A Toledo, Camilo Jimenez, Gustavo Armaiz-Pena, et al.
Cancer Treatment Reviews|July 8, 2014
RAF signaling in neuroendocrine neoplasms: from bench to bedsideNicola Fazio, Omar Abdel-Rahman, Francesca Spada, et al.
Endocrine-Related Cancer|August 1, 2025
Lenvatinib as salvage therapy in advanced and progressive GI-NETAnnie Mathew, Jaume Capdevila, Nicole Unger, et al.
Current Opinion in Oncology|May 5, 2009
Development of new drug strategies in infrequent digestive tumors: esophageal, biliary tract, and anal cancersJaume Capdevila, Francisco Javier Ramos, Teresa Macarulla, et al.
Cancer Treatment Reviews|December 25, 2024
Maintenance therapy after first-line platinum-based chemotherapy in gastroenteropancreatic neuroendocrine carcinomas: A literature reviewNatalia Soledad Tissera, Francesca Balconi, Alejandro García-Álvarez, et al.
Therapeutic Advances in Medical Oncology|August 4, 2022
Cabozantinib combination therapy for the treatment of solid tumors: a systematic reviewDaniel Castellano, Andrea B Apolo, Camillo Porta, et al.
Cancer Treatment Reviews|July 23, 2018
Optimisation of treatment with lenvatinib in radioactive iodine-refractory differentiated thyroid cancerJaume Capdevila, Kate Newbold, Lisa Licitra, et al.
Current Oncology Reports|August 22, 2023
Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line TreatmentNikolaos Andreatos, Patrick W McGarrah, Mohamad Bassam Sonbol, et al.
Pageof 20